*This is the first meta-analysis to fully assess the long-term effects of PDE5i on hard cardiovascular endpoints. The major finding of our analysis is that the use of PDE5i is associated with a reduction of 22% in MACE and 30% in all-cause mortality primarily in middle-aged men with a rather...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.